Aprobarbital
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
5-Propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 77-02-1 |
ATC code | N05CA05 |
PubChem | CID 6464 |
DrugBank | DB01352 |
ChemSpider | 6221 |
UNII | Q0YKG9L6RF |
KEGG | D00698 |
ChEBI | CHEBI:2791 |
ChEMBL | CHEMBL7863 |
Synonyms | Aprobarbital, Oramon, Allylpropymal, Alurate, 5-Isopropyl- 5-allylbarbituric acid |
Chemical data | |
Formula | C10H14N2O3 |
Mol. mass | 210.23 g/mol |
|
|
|
|
(what is this?) (verify) |
Aprobarbital (as known in the United States, or aprobarbitone (as known elsewhere), sold as Oramon, Somnifaine, and Allonal, is a barbiturate derivative invented in the 1920s by Ernst Preiswerk. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia. [1] Aprobarbital was never as widely used as more common barbiturate derivatives such as phenobarbital and is now rarely prescribed as it has been replaced by newer drugs with a better safety margin.
References [edit]
- ^ Reddemann H, Turk E. Oramon poisoning in infancy and childhood. Observations on 12 aprobarbital poisonings (German). Das Deutsche Gesundheitswesen. 1966 May 12;21(19):878-81.
|
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |